IRIS
POZZI, CECILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.211
EU - Europa 5.877
AS - Asia 3.701
SA - Sud America 821
AF - Africa 165
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.100
RU - Federazione Russa 1.264
CN - Cina 1.132
IT - Italia 1.090
SG - Singapore 1.074
GB - Regno Unito 955
IE - Irlanda 861
BR - Brasile 669
VN - Vietnam 468
SE - Svezia 412
HK - Hong Kong 365
FR - Francia 308
UA - Ucraina 282
DE - Germania 247
FI - Finlandia 146
KR - Corea 139
IN - India 138
ZA - Sudafrica 89
BD - Bangladesh 84
CA - Canada 60
AR - Argentina 55
NL - Olanda 55
AT - Austria 39
PL - Polonia 39
TR - Turchia 38
ES - Italia 36
IQ - Iraq 32
BE - Belgio 29
JP - Giappone 29
PK - Pakistan 26
MX - Messico 25
CZ - Repubblica Ceca 24
ID - Indonesia 23
EC - Ecuador 22
SA - Arabia Saudita 21
GR - Grecia 18
CH - Svizzera 17
CL - Cile 17
UZ - Uzbekistan 17
VE - Venezuela 17
CI - Costa d'Avorio 14
IR - Iran 14
CO - Colombia 13
EG - Egitto 13
KE - Kenya 13
PY - Paraguay 13
AU - Australia 11
KZ - Kazakistan 10
NG - Nigeria 10
PT - Portogallo 10
JO - Giordania 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
IL - Israele 8
LT - Lituania 8
MA - Marocco 8
TN - Tunisia 7
UY - Uruguay 7
KG - Kirghizistan 6
MY - Malesia 6
NP - Nepal 6
JM - Giamaica 5
RO - Romania 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
GT - Guatemala 4
HU - Ungheria 4
NO - Norvegia 4
OM - Oman 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AO - Angola 3
LB - Libano 3
LV - Lettonia 3
MD - Moldavia 3
TM - Turkmenistan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
IM - Isola di Man 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
Totale 31.781
Salva come PNG Salva come JPEG
Città #
Dallas 15.095
Dublin 859
Southend 782
Singapore 606
Fairfield 577
Ashburn 489
Santa Clara 398
Moscow 350
Chandler 323
Beijing 319
San Jose 285
Siena 285
Hong Kong 283
Woodbridge 270
Wilmington 240
Seattle 233
Jacksonville 226
Cambridge 199
Houston 199
Ann Arbor 187
Hefei 166
Council Bluffs 165
Princeton 141
Seoul 136
New York 131
Los Angeles 121
Ho Chi Minh City 114
Dong Ket 112
The Dalles 100
Florence 94
Milan 91
Helsinki 87
Fremont 86
Lauterbourg 85
Boardman 83
Nanjing 83
Hanoi 75
Johannesburg 75
Munich 68
San Mateo 55
São Paulo 51
Orem 48
Shanghai 48
Bengaluru 47
Chicago 43
San Diego 41
Buffalo 38
Redondo Beach 37
Sesto Fiorentino 35
Rome 31
Frankfurt am Main 29
London 29
Amsterdam 28
Nanchang 28
Columbus 27
Warsaw 27
Brussels 25
Dearborn 25
Menlo Park 25
Shenyang 25
Nuremberg 23
Vienna 23
Phoenix 22
Tokyo 22
Toronto 22
Chennai 20
Brooklyn 19
Denver 19
Trofarello 19
Belo Horizonte 18
Changsha 18
Kunming 18
Lappeenranta 18
Atlanta 17
Prato 17
Stockholm 17
Guangzhou 16
Redwood City 16
Tashkent 16
Tianjin 16
Brno 15
Da Nang 15
Abidjan 14
Jiaxing 14
Montreal 14
Ningbo 14
Brasília 13
Hebei 13
Jinan 13
Kensington 13
Poplar 13
San Francisco 13
Bologna 12
Boston 12
Düsseldorf 12
Paris 12
Rio de Janeiro 12
Zurich 12
Arezzo 11
Brescia 11
Totale 25.594
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazole-3-Thione analogues with a 2-Ethylbenzoic acid at position 4 as VIM-type metallo-β-Lactamase inhibitors 7.464
1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity 7.356
VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- And metallo-β-lactamases, restores activity of cefepime in enterobacterales and Pseudomonas aeruginosa 351
Amino-thiadiazole as innovative inhibitors of human glutaminyl cyclase, a validated target towards Alzheimer disease 284
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 278
Xanthopsin-like systems via site-specific click-functionalization of a retinoic acid binding protein 278
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 274
Chemistry at the protein-mineral interface in L-ferritin assists the assembly of a functional (μ3-oxo)Tris[(μ2-peroxo)] triiron(III) cluster 273
Crystal structure of the Pseudomonas aeruginosa BEL-1 extended-spectrum β-lactamase and its complexes with moxalactam and imipenem 270
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity 265
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs 263
Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam 259
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 254
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors 253
Targeting class A and C serine β-lactamases with a broad-spectrum boronic acid derivative 252
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery 250
Iron binding to human heavy-chain ferritin 250
Crystal structure of the extended-spectrum β-lactamase BEL-1, in native form and in complex with imipenem and moxalactam. 249
2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives 245
Boric acid and acetate anion binding to subclass B3 metallo-β-lactamase BJP-1 provides clues for mechanism of action and inhibitor design 243
Evidence of destabilization of the human thymidylate synthase (hTS) dimeric structure induced by the interface mutation Q62R 239
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 228
Amino-thiadiazole as innovative inhibitors of human glutaminyl cyclase for the treatment of Alzheimer disease 224
Time-lapse anomalous X-ray diffraction shows how Fe(2+) substrate ions move through ferritin protein nanocages to oxidoreductase sites 221
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model 221
Discovery of ANT3310, a novel broad-spectrum serine β-Lactamase inhibitor of the diazabicyclooctane class, which strongly potentiates meropenem activity against carbapenem-resistant enterobacterales and acinetobacter baumannii 220
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs 218
Effect of the point mutation H54N on the ferroxidase process of Rana catesbeiana H′ ferritin 216
ANT2681: SAR studies leading to the identification of a metallo-β-lactamase inhibitor with potential for clinical use in combination with meropenem for the treatment of infections caused by NDM-Producing enterobacteriaceae 216
Hotspots in an Obligate Homodimeric Anticancer Target. Structural and Functional Effects of Interfacial Mutations in Human Thymidylate Synthase 215
Assisted assembly of a (µ3-oxo)-tris(µ2-peroxo)triiron(III) cluster in L-ferritins and its functional significance. 215
Targeting Methyltransferases in Human Pathogenic Bacteria: Insights into Thymidylate Synthase (TS) and Flavin-Dependent TS (FDTS) 212
Assembly of a Functional Triiron(III) Cluster in L-Ferritin 210
Dynamic interplay between copper toxicity and mitochondrial dysfunction in Alzheimer’s disease 210
In silico identification and in vitro evaluation of natural inhibitors of leishmania major pteridine reductase I 209
X-ray Crystallography Contributions to Drug Discovery Against Parasite 209
Structural and functional characterization of the human thymidylate synthase (hTS) interface variant R175C, new perspectives for the development of hTS inhibitors 207
Structural characterization of a synthetic mimic of the Photoactive Yellow Protein 207
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- And Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections 207
Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells 203
Ferroxidase Activity in Eukaryotic Ferritin is Controlled by Accessory-Iron-Binding Sites in the Catalytic Cavity 200
Probing the role of Arg97 in Heat shock protein 90 N-terminal domain from the parasite Leishmania braziliensis through site-directed mutagenesis on the human counterpart 200
Fibrils of α-Synuclein Abolish the Affinity of Cu2+-Binding Site to His50 and Induce Hopping of Cu2+ Ions in the Termini 199
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor 199
The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders 198
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 197
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 193
Exploiting the bile acid binding protein as transporter of a Cholic Acid/Mirin bioconjugate for potential applications in liver cancer therapy 193
Structural characterization of a synthetic mimic of the Photoactive Yellow Protein 192
Loop electrostatics modulates the intersubunit interactions in ferritin 192
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 186
Crystal structure of Enterococcus faecalis Thymidylate synthase 184
Structural comparison of enterococcus faecalis and human thymidylate synthase complexes with the substrate dUMP and its analogue FdUMP provides hints about enzyme conformational variabilities 183
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase. 181
The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease 171
Morita−Baylis−Hillman Adduct Chemistry as a Tool for the Design of Lysine-Targeted Covalent Ligands 170
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases 167
Structural Insights into the Ferroxidase Site of Ferritins from Higher Eukaryotes 167
Editorial for the special issue: “targeting β- lactamases to fight bacterial resistance to β-Lactam antibiotics” 162
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1 160
CRYSTAL STRUCTURE OF A COMPLEX OF THYMIDYLATE SYNTHASE (TS) WITH A LIGAND 158
Structural insight into iron pathways in ferritin 157
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design 156
Identification of the Binding Modes of N-Phenylphthalimides Inhibiting Bacterial Thymidylate Synthase through X-Ray Crystallography Screening 155
Structural and mechanistic insights into iron processing and biomineralization by vertebrate ferritins 154
Iron Biomineral Growth from the Initial Nucleation Seed in L-Ferritin 154
Evolution to carbapenem-hydrolyzing activity in class D β-lactamases by rational protein design 150
Structural insight into iron pathways in ferritin 149
Evolution to carbapenem -hydrolyzing activity in noncarbapenemase class D beta-lactamase OXA-10 by rational protein design 149
Probing the role of Arg97 in the parasite Leishmania braziliensis Hsp90 through site directed mutagenesis on the human counterpart 149
Structural characterization of human heat shock protein 90 N-Terminal domain and its variants K112R and K112A in complex with a potent 1,2,3-Triazole-based inhibitor 148
Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase 148
Metal ion binding to human Glutaminyl Cyclase: a structural perspective 148
Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates 140
Assisted assembly and growth of iron-oxide mineral particles in human L-ferritin, new insight to unveil the biomineralization process 140
Structural and functional characterization of new human thymidylate synthase interface variants 132
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 131
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 130
Structural and functional characterization of new human thymidylate synthase interface variants 130
Iron Binding in the Ferroxidase Site of Human Mitochondrial Ferritin 128
Structural and mechanistic insights into the iron processing by vertebrate ferritins 126
High resolution iron derivative of bullfrog M ferritin: structural insight into ferroxidase process 125
Probing the role of Arg97 in the parasite Leishmania braziliensis Hsp90 through site directed mutagenesis on the human counterpart 120
Validation of recombinant chicken liver bile acid binding protein as a tool for cholic acid hosting 117
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism. 115
Structural comparison between Enterococcus faecalis and human thymidylate synthase provides hints about enzyme conformational variabilities 115
Staphylococcus aureus-associated skin and soft tissue infections: Anatomical localization, epidemiology, therapy and potential prophylaxis 115
Structural and mechanistic insights into the iron processing by vertebrate ferritins 113
Crystallographic studies of new human Thymidylate synthase inhibitors. 112
Crystallographic studies of new human Thymidylate synthase inhibitors 111
Crystallographic studies of new human Thymidylate synthase inhibitors 110
Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations 109
Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules 101
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics 58
null 52
Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-Trypanosoma brucei Agents 35
Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization Approach 24
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 24
Totale 32.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 0 0 183
2021/20221.252 49 137 110 136 89 42 53 67 58 126 150 235
2022/20231.433 100 103 222 143 154 309 40 117 148 25 39 33
2023/20241.553 56 34 112 67 74 349 535 30 14 40 36 206
2024/20252.970 127 130 273 153 373 168 143 194 215 151 380 663
2025/202620.690 455 4.457 11.316 1.064 1.269 251 662 200 307 371 244 94
Totale 32.200